Company intelligence / Profile preview

Gaylord Chemical

Covington, Louisiana, United Statesgaylordchemical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Gaylord Chemical does not develop therapeutics but manufactures pharmaceutical-grade DMSO under the Procipient® brand, which meets USP and Ph. Eur. standards and supports regulatory filings globally. Their DMSO product has Type II DMF with FDA, CEP from EDQM, Type I DMF with Health Canada, cGMP manufacturing per ICH Q7 guidelines, and global regulatory support. No clinical results as they do not run clinical trials themselves.

Modalities: Small molecule excipient/solvent (Dimethyl sulfoxide/DMSO)Small molecule solvent (Dimethyl sulfide/DMS)Excipient for parenteral/topical drug delivery
Industry: Chemicals & Materials

Drug pipeline

1 asset

Procipient

Commercial

Indications: Drug delivery, Pharmaceutical excipient

Beyond the preview

Go deeper on Gaylord Chemical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gaylord Chemical.

Explore the full profile